FDA Leadership Changes

News

FDA Appoints Biotech Exec

FDA Names Former Pharmaceutical Executive To Oversee U.S. Drug Program

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs.

Politico · 3d

Makary ally named to key FDA drug post

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

RealClearPolitics · 4d

FDA Appoints Biotech Exec as Top Drug Regulator

Marty Makary, commissioner of the FDA, is naming George Tidmarsh director of the Center for Drug Evaluation and Research.<br /> <br />

Fierce Pharma11d

Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues

The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...

JD Supra1mon

Staying Prepared Amid FDA Changes | Gardner Law - JDSupra

Despite recent staffing reductions and leadership transitions at the FDA, pharmaceutical and medical device manufacturers should not interpret these changes as a signal of reduced regulatory ...

Seattle Times2mon

WA vaccine scientists push back against FDA changes around COVID shots

WA vaccine scientists push back against FDA changes around COVID shots . May 21, 2025 at 6:00 am Updated May 21, 2025 at 6:01 am . By . Elise Takahama. Seattle Times staff reporter.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results